Discovery of new quinazolin-4-ones as dual EGFR/c-SRC inhibitors with potential to overcome bypass-mediated resistance in cancer
Fields of Study & Subjects
Quinazolinone synthesis and applications
HER2/EGFR in Cancer Research
Chemotherapy-induced cardiotoxicity and mitigation
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 315
- Pages
- 118985–118985
- Publication date
- 20 May 2026
- Language
- EN